IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 61 a 80 di 530
Titolo Data di pubblicazione Autore(i) File
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease 1-gen-2001 Fiorentino, C.; Berruti, A.; Bottini, A.; Bodini, M.; Brizzi, M. P.; Brunelli, A.; Marini, U.; Allevi, G.; Aguggini, S.; Tira, A.; Alquati, P.; Olivetti, L.; Dogliotti, L.
Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: a single institution phase II study. 1-gen-2001 Bretti, S; Manzin, E; Celano, A; Ritorto, G; Loddo, C; Berruti, Alfredo
Reversible pancytopenia caused by oral letrozole assumption in a patient with recurrent breast cancer. 1-gen-2002 Sperone, P; Gorzegno, G; Berruti, Alfredo; Familiari, U; Dogliotti, L.
Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. 1-gen-2002 Berruti, Alfredo; Dogliotti, L; Terrone, C; Cerutti, S; Isaia, G; Tarabuzzi, R; Reimondo, G; Mari, M; Ardissone, P; DE LUCA, S; Fasolis, G; Fontana, D; Rossetti, Sr; Angeli, A.
Hyperparathyroidism due to the so-called bone hunger syndrome in prostate cancer patients. 1-gen-2002 Berruti, Alfredo; Dogliotti, L; Tucci, M; Scarpa, Rm; Angeli, A.
Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer. 1-gen-2002 Bottini, A; Berruti, Alfredo; Bersiga, A; Brizzi, Mp; Allevi, G; Bolsi, G; Aguggini, S; Brunelli, A; Betri, E; Generali, D; Scaratti, L; Bertoli, G; Alquati, P; Dogliotti, L.
Background to and management of treatment-related bone loss in prostate cancer. 1-gen-2002 Berruti, Alfredo; Tucci, M; Terrone, C; Gorzegno, G; Scarpa, Rm; Angeli, A; Dogliotti, L.
Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design. 1-gen-2002 Berruti, Alfredo; Bitossi, R; Gorzegno, G; Bottini, A; Alquati, P; DE MATTEIS, A; Nuzzo, F; Giardina, G; Danese, S; DE LENA, M; Lorusso, V; Farris, A; Sarobba, Mg; Defabiani, E; Bonazzi, G; Castiglione, F; Bumma, C; Moro, G; Bruzzi, P; Dogliotti, L.
Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma. 1-gen-2002 Berruti, Alfredo; Tucci, M; Dogliotti, L; Scarpa, Rm; Angeli, A.
Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastases. 1-gen-2002 Berruti, Alfredo; Dogliotti, L; Tucci, M; Tarabuzzi, R; Guercio, S; Torta, M; Tampellini, M; Dovio, A; Poggio, M; Scarpa, Rm; Angeli, A.
Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a phase II study. 1-gen-2003 Bretti, S; Manzin, E; Loddo, C; Berruti, Alfredo; Bombaci, S; Vellani, G; Celano, A.
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study. 1-gen-2003 Donadio, M; Ardine, M; Berruti, Alfredo; Ritorto, G; Fea, E; Mistrangelo, M; Coccorullo, Z; Bergnolo, P; Comandone, A; Bertetto, O.
p53 expression and disease outcome of breast cancer patients undergoing primary chemotherapy with anthracycline-containing regimens. 1-gen-2003 Bottini, A; Dogliotti, L; Bersiga, A; Brizzi, Mp; Berruti, Alfredo
Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2] 1-gen-2003 Atkins, Carl D; Rosenthal, Mark; Berruti, Alfredo; Tucci, Marcello; Terrone, Carlo; Scarpa, Roberto Mario; Angeli, Alberto; Dogliotti, Luigi; Saad, Fred; Gleason, Donald M.; Murray, Robin; Goas, J. Allen; Chen, Bee
Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer. 1-gen-2003 Bottini, A; Berruti, Alfredo; Brizzi, Mp; Bersiga, A; Generali, D; Allevi, G; Aguggini, S; Bolsi, G; Bonardi, S; Bertoli, G; Alquati, P; Dogliotti, L.
Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. 1-gen-2003 Berruti, Alfredo; Tucci, M; Terrone, C; Scarpa, Rm; Angeli, A; Dogliotti, L.
Durable complete remission after weekly docetaxel administration in a patient with mediastinal non-seminomatous germ-cell tumor refractory to cisplatin-based chemotherapy 1-gen-2003 Berruti, Alfredo; A., Saini; G., Gorzegno; M., Tampellini; P., Borasio; L., Dogliotti
CIRCADIAN RHYTHM OF BONE TURNOVER MARKERS INBREAST CANCER PATIENTS WITH METASTATIC BONE DISEASE ANDIN CONTROL SUBJECTS 1-gen-2004 Daniele, Generali; Sara, Tedoldi; Alberto, Bottini; Berruti, Alfredo; Marco, Tampellini; Marcello, Tucci; Giovanni, Allevi; Mirella, Torta; Simone, Bonardi; Manuela, Milani; Sergio, Aguggini; Alberto, Angeli; Luigi, Dogliotti
THE ROLE OF HEMOGLOBIN LEVEL IN PREDICTING THE RESPONSE TO FIRST-LINE CHEMOTHERAPY IN ADVANCED COLORECTAL CANCER (ACC) PATIENTS 1-gen-2004 Marco, Tampellini; Andrea, Saini; Irene, Alabiso; Raffaella, Bitossi; Maria Pia, Brizzi; Berruti, Alfredo; Gabriella, Gorzegno; Stefania, Miraglia; Oscar, Alabiso; Luigi, Dogliotti
Endocrine tumros of the gastrointestinal tract 1-gen-2004 Berruti, Alfredo; Brizzi, Mp; Dogliotti, L.
Mostrati risultati da 61 a 80 di 530
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile